Your session is about to expire
← Back to Search
Epic Smartlist Implementation for Colorectal Cancer Screening Follow-Up (ColoSET Trial)
N/A
Waitlist Available
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights
ColoSET Trial Summary
This trial seeks to improve accuracy of follow-up after colonoscopy screening, reducing risk of colorectal cancer and restoring trust in providers.
Who is the study for?
This trial is for gastrointestinal specialists at MGH who perform screening and surveillance colonoscopies aimed at colorectal cancer prevention. It's not open to those who aren't currently performing these procedures.Check my eligibility
What is being tested?
The study tests a new system for updating follow-up intervals in patient records after colonoscopy, using Epic Smartlist, against the current method. The goal is to improve adherence to guidelines and reduce errors in scheduling follow-ups.See study design
What are the potential side effects?
Since this trial involves an administrative process rather than a medical treatment, there are no direct physical side effects associated with the interventions being tested.
ColoSET Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Implement a new process using a structured result letter template to set the electronic health record follow-up interval after a screening colonoscopy.
ColoSET Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Group II: ControlActive Control1 Intervention
Find a Location
Who is running the clinical trial?
Massachusetts General HospitalLead Sponsor
2,928 Previous Clinical Trials
13,198,312 Total Patients Enrolled
Harvard Risk Management FoundationOTHER
6 Previous Clinical Trials
31,101 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not currently performing colonoscopies.I am a GI specialist performing colonoscopies at MGH.
Research Study Groups:
This trial has the following groups:- Group 1: Intervention
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still opportunities to take part in this experiment?
"Clinicaltrials.gov reports that this medical trial is still in the process of recruiting patients, with its initial posting on November 18th 2022 and most recent update on 29th of the same month."
Answered by AI
How many participants are actively engaged in this clinical trial?
"Affirmative. Data on clinicaltrials.gov attests that this research experiment, which was first advertised on November 18th 2022, is actively recruiting participants. Approximately 60 persons are needed to be enrolled from a single medical facility."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger